Can Nanotechnology improve drug delivery to the brain?
Yes, nanoparticles can be engineered to deliver drugs across the blood-brain barrier, which is a major hurdle in treating neurological diseases. Nanocarriers, such as liposomes, dendrimers, and polymeric nanoparticles, can be designed to release therapeutic agents in a controlled manner, enhancing the efficacy and reducing the side effects of drugs used to treat conditions like Alzheimer's disease, Parkinson's disease, and brain tumors.
